A sum of 90 patients participated with a confirmed diagnosis of cardiovascular disease and/or rheumatoid arthritis and/or osteoarthritis and a C-reactive protein level of more than 1.0 mg/dL for 3 consecutive weeks. This evidence concerns the gene CRP and rheumatoid arthritis.